Verified Service Provider in Burkina Faso
Molecular Diagnostics Labs in Burkina Faso
Engineering Excellence & Technical Support
Molecular Diagnostics Labs solutions for Clinical & Diagnostic Labs. High-standard technical execution following OEM protocols and local regulatory frameworks.
Rapid Diagnostic Kits for Point-of-Care Testing
Deployment of advanced, user-friendly rapid diagnostic kits enables faster and more accessible disease detection at the point-of-care, improving patient outcomes and reducing the burden on centralized laboratories.
Genomic Sequencing for Pathogen Surveillance
Implementation of next-generation sequencing technologies allows for real-time tracking of infectious disease outbreaks, identification of novel strains, and informed public health response strategies in Burkina Faso.
Automated Sample Processing and Analysis
Introduction of automated platforms for sample preparation and molecular analysis significantly increases throughput, reduces human error, and enhances the reliability of diagnostic results, particularly for high-volume testing.
What Is Molecular Diagnostics Labs In Burkina Faso?
Molecular diagnostics laboratories in Burkina Faso are specialized healthcare facilities equipped to perform tests that analyze biological molecules, primarily DNA and RNA, to identify infectious agents, assess genetic predispositions to diseases, and monitor treatment efficacy. These laboratories leverage advanced techniques such as Polymerase Chain Reaction (PCR), nucleic acid sequencing, and microarrays to achieve high sensitivity and specificity in disease detection and characterization. The establishment and operation of these labs are critical for strengthening Burkina Faso's public health infrastructure, particularly in response to emerging infectious diseases and the management of chronic conditions. They play a pivotal role in disease surveillance, outbreak investigation, and personalized medicine initiatives within the country's healthcare system.
| Who Needs Molecular Diagnostics | Typical Use Cases | Impact in Burkina Faso |
|---|---|---|
| Individuals with suspected infectious diseases: Patients exhibiting symptoms of viral, bacterial, or parasitic infections. | Diagnosis of viral infections: Detection of HIV, Hepatitis B/C, Influenza, Dengue, Ebola, and COVID-19. Identification of drug-resistant strains (e.g., malaria). | Enhanced disease surveillance: Early detection of outbreaks and tracking of endemic infectious diseases, crucial for public health interventions. |
| Individuals with genetic predispositions or inherited diseases: Family members of patients with known genetic disorders, or individuals with clinical signs suggestive of such conditions. | Screening for genetic disorders: Testing for conditions like sickle cell anemia, cystic fibrosis, or certain inherited cancers. Pharmacogenomic testing to guide drug selection and dosage. | Improved management of non-communicable diseases: Facilitating early diagnosis and personalized treatment strategies for conditions with a genetic component. |
| Cancer patients: Individuals diagnosed with or suspected of having cancer. | Oncology testing: Identification of specific genetic mutations in tumors for targeted therapy selection, monitoring treatment response, and detecting minimal residual disease. | Advancement of cancer care: Enabling more precise and effective treatment protocols for oncological conditions, potentially improving patient outcomes. |
| Public health authorities and research institutions: Government health ministries, national disease control centers, and academic research bodies. | Epidemiological studies: Investigating disease transmission patterns, identifying reservoirs, and assessing the burden of disease within the population. Supporting research and development of new diagnostic tools and vaccines. | Strengthened national health security: Providing critical data for policy-making, resource allocation, and preparedness for public health emergencies. |
Key aspects of Molecular Diagnostics Labs in Burkina Faso:
- Purpose: To provide advanced diagnostic capabilities for infectious diseases, genetic disorders, and oncology.
- Methodologies: Primarily PCR-based assays (RT-PCR, real-time PCR), nucleic acid sequencing, and other molecular hybridization techniques.
- Infrastructure: Requires specialized equipment (thermocyclers, sequencers, biosafety cabinets), reagents, trained personnel (molecular biologists, medical technologists), and stringent quality control measures.
- Regulatory Framework: Subject to national health regulations and international standards for laboratory practice and biosafety.
Who Needs Molecular Diagnostics Labs In Burkina Faso?
Molecular diagnostics laboratories are crucial for accurate and timely disease detection, identification, and management in Burkina Faso. They offer advanced testing capabilities that go beyond traditional methods, enabling precise diagnosis of infectious diseases, genetic disorders, and cancers. This leads to more targeted treatment, better patient outcomes, and enhanced public health surveillance.
| Customer Segment | Primary Needs/Applications | Impact of Molecular Diagnostics |
|---|---|---|
| Public Health Facilities | Diagnosis of endemic and epidemic infectious diseases (Malaria, TB, HIV, Cholera, Meningitis, Viral Hemorrhagic Fevers). Detection of antimicrobial resistance. Genetic screening. Outbreak investigation. | Improved disease surveillance, early outbreak detection, effective treatment regimens, reduced mortality and morbidity, evidence-based public health policy. |
| Private Healthcare Providers | Accurate and rapid diagnosis for patient management. Differentiated testing for better treatment selection. Screening for sexually transmitted infections. | Enhanced patient care, improved diagnostic accuracy, increased patient satisfaction, competitive advantage. |
| Research Institutions | Disease pathogenesis studies, drug discovery and development, epidemiological research, genomic sequencing. | Advancement of scientific knowledge, development of new diagnostics and therapeutics, capacity building in research. |
| Blood Banks and Organ Transplant Centers | Screening of blood donors and organ donors for infectious agents (e.g., HIV, HBV, HCV, CMV). HLA typing for transplant compatibility. | Ensuring blood and organ safety, reducing transmission of infections, improving transplant success rates. |
| Veterinary Services & Agriculture | Diagnosis of zoonotic diseases (e.g., Avian Influenza, Rabies, Brucellosis). Disease control in livestock and poultry. Food safety testing. | Prevention of human-animal disease transmission, protection of agricultural economy, ensuring food security. |
Who Needs Molecular Diagnostics Labs in Burkina Faso? Target Customers & Departments
- {"items":["Public Health Facilities (Hospitals, Clinics, Health Centers)","Private Healthcare Providers","Research Institutions","Blood Banks and Organ Transplant Centers","Veterinary Services (for zoonotic diseases)","Poultry and Livestock Farmers (for disease outbreaks)","Food and Beverage Industry (for safety testing)","Environmental Agencies (for pathogen detection)"],"title":"Target Customers"}
- {"items":["Infectious Disease Units (e.g., for HIV, TB, Malaria, emerging infectious diseases)","Oncology Departments (for cancer diagnosis and monitoring)","Hematology and Blood Transfusion Services","Pediatric Departments (for genetic disorders and infectious diseases in children)","Gynecology and Obstetrics (for prenatal screening and infections)","Emergency Departments (for rapid diagnosis of life-threatening conditions)","Pathology and Laboratory Services","Epidemiology and Public Health Surveillance Units"],"title":"Key Departments/Users within Healthcare Facilities"}
Molecular Diagnostics Labs Process In Burkina Faso
This document outlines the typical workflow for molecular diagnostics laboratory processes in Burkina Faso, from the initial inquiry to the final execution of tests. The process involves several key stages, including sample reception, accessioning, preparation, testing, data analysis, and reporting. While specific protocols may vary slightly between laboratories, the general principles remain consistent.
| Stage | Key Activities | Responsible Personnel | Common Challenges in Burkina Faso | Mitigation Strategies |
|---|---|---|---|---|
| Inquiry & Sample Collection | Requesting test, collecting biological sample, ensuring proper labeling. | Clinician, Nurse, Laboratory Technician. | Lack of awareness of available tests, improper collection techniques, insufficient sample volume, poor sample labeling. | Training healthcare workers, providing clear collection guidelines and materials, supervised collection where possible. |
| Sample Transportation | Transporting samples under specified conditions (cold chain, secure packaging). | Courier, Laboratory Assistant. | Inadequate cold chain infrastructure, unreliable transportation networks, long distances, security risks. | Utilizing insulated containers, establishing local collection points, partnering with reliable transport services, implementing real-time temperature monitoring. |
| Sample Reception & Accessioning | Receiving samples, logging into LIMS, assigning accession numbers, initial QC check. | Laboratory Technician, Data Entry Clerk. | Power outages affecting LIMS, delays in sample logging, errors in data entry, missing sample documentation. | Uninterruptible Power Supplies (UPS) for LIMS, rigorous double-checking of data, clear protocols for handling missing information. |
| Nucleic Acid Extraction | Isolating DNA/RNA from the sample. | Laboratory Technician, Molecular Biologist. | Variability in kit performance, reagent shortages, cross-contamination, insufficient extraction yield. | Strict adherence to protocols, regular QC of reagents, dedicated extraction areas, using appropriate controls. |
| Molecular Assay (PCR/RT-PCR) | Amplifying and detecting target genetic material. | Molecular Biologist, Laboratory Technician. | Instrument downtime, reagent instability, power fluctuations affecting thermocyclers, skilled personnel shortages. | Regular instrument maintenance, proper reagent storage, UPS for critical equipment, ongoing training and capacity building. |
| Data Analysis & Reporting | Interpreting results, generating reports, communicating findings. | Molecular Biologist, Laboratory Manager. | Software glitches, interpretation errors, delays in reporting, communication breakdowns with clinicians. | Regular software updates and validation, robust interpretation guidelines, clear communication channels, standardized reporting templates. |
| Quality Assurance | Monitoring all stages, internal/external QC, proficiency testing. | Quality Manager, Laboratory Manager. | Lack of access to external QC samples, limited participation in proficiency testing, insufficient internal QC data. | Establishing strong partnerships for QC access, prioritizing proficiency testing participation, regular review of internal QC data and implementing corrective actions. |
Molecular Diagnostics Lab Workflow in Burkina Faso
- Inquiry/Request Initiation: This begins with a healthcare provider or public health official identifying a need for molecular diagnostic testing. This can stem from patient care, outbreak surveillance, or research purposes.
- Sample Collection: The appropriate biological sample (e.g., blood, urine, sputum, swabs, cerebrospinal fluid) is collected from the patient or the environment according to standardized protocols.
- Sample Transportation: Samples are transported to the molecular diagnostics laboratory under appropriate conditions (e.g., cold chain, secure packaging) to maintain sample integrity.
- Sample Reception and Registration: Upon arrival, samples are received, logged, and registered into the laboratory's Laboratory Information Management System (LIMS). Each sample is assigned a unique accession number.
- Sample Quality Control (QC) Check: A preliminary assessment of the sample is performed to ensure it meets pre-defined quality criteria (e.g., sufficient volume, proper labeling, absence of contamination).
- Sample Storage: Validated samples are stored appropriately (e.g., at -20°C or -80°C) pending further processing.
- Nucleic Acid Extraction: The target nucleic acid (DNA or RNA) is extracted from the biological sample using validated kits or protocols. This is a critical step to isolate the genetic material for subsequent amplification.
- Nucleic Acid Quality and Quantity Assessment: The extracted nucleic acid is assessed for purity and concentration using methods like spectrophotometry (e.g., NanoDrop) or fluorometry (e.g., Qubit).
- Reagent Preparation and QC: All reagents required for the molecular assay are prepared, aliquoted, and subjected to quality control checks to ensure their performance.
- Molecular Assay (e.g., PCR, RT-PCR, Sequencing): The extracted nucleic acid is subjected to the specific molecular assay. This typically involves amplification of target genetic sequences.
- Amplification and Detection: The amplified products are detected and analyzed using appropriate instrumentation (e.g., real-time PCR thermocyclers, sequencers).
- Data Analysis and Interpretation: Raw data from the instrument is analyzed using specialized software. This involves identifying positive/negative results, quantifying targets, or interpreting sequencing data.
- Result Validation: Results are reviewed by qualified laboratory personnel to ensure accuracy and consistency. Internal and external quality control samples are monitored.
- Reporting of Results: A formal report is generated containing the test results, patient information, and relevant technical details. This report is then transmitted to the requesting healthcare provider or relevant authority.
- Archiving: Samples, reagents, and associated data are archived according to laboratory policy and regulatory requirements for future reference or audits.
- Troubleshooting and Continuous Improvement: Any issues encountered during the process are documented, investigated, and addressed. Feedback is used to refine protocols and improve laboratory efficiency and quality.
Molecular Diagnostics Labs Cost In Burkina Faso
Molecular diagnostics labs play a crucial role in disease detection and management in Burkina Faso. The cost of molecular diagnostic tests can vary significantly due to a multitude of factors, making it challenging to provide a single, definitive price list. These factors influence the affordability and accessibility of these vital health services for the population. Understanding these pricing dynamics is essential for healthcare providers, patients, and policymakers to ensure equitable access to diagnostic testing. The local currency in Burkina Faso is the West African CFA franc (XOF).
| Test Type (Example) | Estimated Price Range (XOF) | Notes |
|---|---|---|
| Malaria PCR | 15,000 - 30,000 | Detects Plasmodium parasites with higher sensitivity than microscopy. |
| HIV Viral Load (PCR) | 25,000 - 45,000 | Essential for monitoring HIV treatment effectiveness. |
| Tuberculosis (TB) PCR (e.g., GeneXpert) | 20,000 - 40,000 | Rapid and accurate diagnosis of TB, including drug-resistant strains. |
| Hepatitis B/C Viral Load (PCR) | 25,000 - 45,000 | Used for diagnosis and monitoring of hepatitis infections. |
| COVID-19 RT-PCR | 15,000 - 30,000 | The standard for accurate COVID-19 detection. Prices have fluctuated with demand. |
| Sexually Transmitted Infections (STI) Panel (e.g., Gonorrhea, Chlamydia) | 30,000 - 60,000 | Detects multiple pathogens simultaneously. |
| Basic Genetic Testing (e.g., for specific inherited conditions) | 50,000 - 150,000+ | Highly dependent on the specific gene(s) tested and the technology used. |
Key Pricing Factors for Molecular Diagnostics in Burkina Faso
- Reagent Costs: The price of specialized reagents and consumables, often imported, is a major determinant. Fluctuations in international supply chains and currency exchange rates directly impact local pricing.
- Equipment and Technology: The initial investment in sophisticated molecular diagnostic equipment (e.g., PCR machines, sequencers) and ongoing maintenance costs are factored into test prices.
- Labor and Expertise: Skilled personnel, including laboratory technicians and molecular biologists, are required to perform and interpret these tests. Their salaries contribute to the overall cost.
- Laboratory Overheads: This includes rental costs, electricity, water, waste disposal, and administrative expenses, all of which are reflected in the pricing.
- Test Complexity: More complex tests, such as multi-pathogen panels or genetic sequencing, naturally incur higher costs due to specialized reagents, longer processing times, and greater expertise required.
- Import Duties and Taxes: Taxes and import duties on diagnostic kits and equipment can significantly increase their landed cost in Burkina Faso.
- Volume of Testing: Laboratories that perform a higher volume of tests may benefit from economies of scale, potentially leading to lower per-test prices.
- Government Subsidies and Funding: The availability of government subsidies or funding from international organizations can influence the final price offered to patients, sometimes making tests more affordable.
- Location of the Lab: Labs in urban centers might have different operational costs compared to those in rural areas, which can affect pricing.
- Type of Lab (Public vs. Private): Public health laboratories may offer subsidized rates compared to private commercial laboratories.
Affordable Molecular Diagnostics Labs Options
For individuals and healthcare providers seeking cost-effective molecular diagnostics, several options and strategies can significantly reduce expenses. Understanding the landscape of affordable labs and implementing smart purchasing decisions are key. This often involves looking beyond traditional, high-volume hospital labs or specialized niche providers and exploring dedicated diagnostic companies that focus on efficiency and volume. Value bundles and proactive cost-saving strategies can transform the accessibility and affordability of crucial molecular testing.
| Strategy | Description | Benefits | Considerations |
|---|---|---|---|
| Value Bundles | Purchasing a set of related molecular tests together at a discounted price. For example, a panel for infectious diseases or a comprehensive cancer genetic mutation panel. | Reduced overall cost per test, streamlined ordering for related conditions, comprehensive insights. | Ensure the bundle aligns with clinical needs; avoid unnecessary tests within a bundle. |
| Negotiated Contracts/Volume Discounts | For healthcare providers or larger organizations, negotiating directly with labs for volume-based pricing or long-term contracts. | Significant cost savings for high-volume users, predictable pricing, stronger lab relationships. | Requires procurement expertise and commitment to specific lab partners. |
| Insurance Verification and Pre-authorization | Thoroughly checking insurance coverage and obtaining pre-authorization for molecular tests to avoid unexpected out-of-pocket expenses. | Minimizes patient financial burden, prevents claim denials, ensures covered services. | Requires diligent administrative work and knowledge of insurance policies. |
| Exploring Payment Plans and Financial Assistance | Inquiring about payment plans offered by the lab or identifying financial assistance programs (patient advocacy groups, lab-specific aid) for out-of-pocket costs. | Makes testing more accessible for patients with financial constraints, spreads costs over time. | May involve application processes and eligibility criteria. |
| Utilizing Telehealth for Consultation and Ordering | Leveraging telehealth platforms for initial consultations and test ordering can reduce overhead associated with in-person visits, potentially leading to lower overall diagnostic costs. | Convenience, accessibility, potential cost reduction through reduced physical infrastructure needs. | Requires reliable internet access and patient comfort with virtual interactions. |
| Comparative Shopping | Actively comparing pricing and turnaround times from different reputable molecular diagnostic labs for specific tests. | Ensures the best possible price for a given quality of service, fosters competition among labs. | Requires research and understanding of test specifications. |
Affordable Molecular Diagnostics Lab Options
- Direct-to-Consumer (DTC) Genetic Testing Companies: While often focused on ancestry and wellness, some DTC providers offer disease risk assessment or pharmacogenomic testing at competitive price points. However, it's crucial to verify the clinical validity and utility of these tests and consult with a healthcare professional for interpretation.
- Regional Reference Laboratories: Many regions have established reference labs that handle a high volume of tests for multiple healthcare systems. These labs often achieve economies of scale, leading to lower per-test costs. Inquire with your local healthcare providers about the labs they utilize.
- Specialized Telehealth Diagnostic Platforms: Emerging platforms are integrating molecular testing with telehealth services. They often offer streamlined ordering, sample collection kits, and reporting directly to patients or their doctors, potentially cutting down on administrative overhead and associated costs.
- Outreach Programs from Larger Hospital Systems: Some major hospital networks offer their molecular diagnostic services to smaller clinics or independent practitioners. These outreach programs can provide access to advanced testing at potentially more affordable rates than accessing it independently through a full-service hospital.
- Partnerships with Academic Medical Centers: Certain academic centers may offer testing services to the public or partner with local health organizations, especially for more specialized or research-oriented molecular tests. Their focus on education and research can sometimes translate to competitive pricing for established assays.
Verified Providers In Burkina Faso
In Burkina Faso, identifying trusted and verified healthcare providers is paramount for ensuring quality medical care. Franance Health has established itself as a leading authority in credentialing and verifying healthcare professionals and institutions across the nation. Their rigorous vetting process and commitment to upholding high standards make them the best choice for anyone seeking reliable medical services. This document outlines what Franance Health credentials entail and the compelling reasons why they signify the highest level of trust and competence in Burkina Faso's healthcare landscape.
| Attribute | Franance Health Verification | Why it Matters for Patients |
|---|---|---|
| Medical Licenses & Certifications | Thoroughly checked and confirmed valid. | Guarantees the provider is legally authorized and qualified to practice medicine. |
| Educational Background | Verified from accredited institutions. | Ensures a strong foundation of medical knowledge and training. |
| Clinical Experience | Assessed for relevance and duration. | Indicates practical expertise and familiarity with various medical conditions. |
| Professional Reputation | May include peer reviews or background checks (depending on scope). | Offers an indicator of consistent quality of care and patient satisfaction. |
| Adherence to Best Practices | Evaluated against established medical guidelines. | Assures patients they are receiving care that aligns with current medical standards. |
What Franance Health Credentials Signify:
- Rigorous Verification of Qualifications: Franance Health meticulously scrutinizes the educational background, professional licenses, and certifications of all healthcare providers they credential. This ensures that practitioners possess the necessary theoretical knowledge and practical skills.
- Extensive Experience Assessment: Beyond academic achievements, Franance Health evaluates the practical experience of providers, including their years in practice, specialization, and any relevant clinical achievements or contributions.
- Adherence to Ethical Standards: A crucial aspect of Franance Health's credentialing is the assessment of a provider's commitment to ethical medical practices, patient confidentiality, and professional conduct.
- Continuous Professional Development Monitoring: Franance Health often requires providers to demonstrate ongoing engagement in continuing medical education and professional development to stay abreast of the latest advancements in their fields.
- Patient Safety Protocols and Compliance: Verified providers through Franance Health are expected to adhere to stringent patient safety protocols and regulatory compliance measures within their practice.
- Institutional Quality Assurance (for facilities): For healthcare facilities, Franance Health credentials indicate adherence to established standards for infrastructure, equipment, hygiene, and operational efficiency.
Scope Of Work For Molecular Diagnostics Labs
This Scope of Work (SOW) outlines the technical deliverables and standard specifications for Molecular Diagnostics Laboratories. It aims to define the requirements for establishing, operating, and maintaining a robust molecular diagnostics facility capable of performing a wide range of tests. This document will serve as a guide for laboratory setup, equipment acquisition, validation, quality control, and operational procedures.
| Technical Deliverable | Standard Specification/Requirement | Description/Notes |
|---|---|---|
| Laboratory Layout and Design | ISO 15189 or CLIA compliant, distinct pre-PCR, post-PCR, and extraction zones | Ensures adequate workflow, prevents contamination, and adheres to biosafety level requirements. |
| Nucleic Acid Extraction Instruments | Automated systems with high throughput and traceability | Capacities ranging from 24 to 96 samples per run, with integrated barcoding and LIMS connectivity. |
| PCR/qPCR Instruments | Real-time PCR thermocyclers with multiplexing capabilities (e.g., 4-plex or higher) | Fast cycling times, high sensitivity, optical accuracy, and gradient functionality for optimization. |
| Next-Generation Sequencing (NGS) Platforms | Illumina MiSeq/NextSeq or equivalent, with paired-end sequencing capabilities | Scalable throughput, high accuracy, and comprehensive data analysis pipelines for various applications (e.g., targeted sequencing, whole-genome sequencing). |
| Automated Liquid Handling Systems | Robotic platforms for sample preparation and assay setup | High precision, repeatability, adaptable for various plate formats and tube types, with integrated software for protocol design. |
| Biosafety Cabinets (BSCs) | Class II Type A2 or B2 depending on application | Certified and regularly maintained for personnel, product, and environmental protection. |
| Incubators and Environmental Chambers | Temperature and humidity controlled, with alarms | For reagent storage, cell culture (if applicable), and stability studies. |
| Refrigerator and Freezer Units | Temperature-monitored, with alarms and backup power | Specific temperature ranges (e.g., +4°C, -20°C, -80°C) for reagent and sample storage. |
| Laboratory Information Management System (LIMS) | Secure, auditable, and compliant with HIPAA/GDPR | Sample tracking, data entry, result generation, reporting, inventory management, and QC monitoring. |
| Validated Molecular Assays | According to CLIA, FDA, or CE-IVD guidelines | Includes performance characteristics (sensitivity, specificity, accuracy, precision, linearity, LoD, LoQ, interference, etc.) and documented SOPs. |
| Quality Control (QC) Materials | Commercial or in-house developed controls with defined target values | Positive, negative, and quantitative controls for each assay, with established QC rules (e.g., Westgard rules). |
| Reagent Traceability System | Barcoding and lot number tracking | Ensures the use of approved reagents, monitors expiry dates, and facilitates recalls if necessary. |
| Personnel Training Records | Documented training for all laboratory personnel | Includes initial training, ongoing competency assessment, and specialized training for new assays/equipment. |
| Instrument Calibration and Maintenance Logs | Regularly scheduled preventive maintenance and calibration | Records of all service, repairs, and calibration events for each instrument. |
| Biosafety Manual | Comprehensive and updated regularly | Outlines procedures for safe handling of biological agents, waste disposal, and emergency response. |
Key Areas Covered in the Scope of Work
- Laboratory Design and Infrastructure
- Equipment and Instrumentation
- Reagents and Consumables
- Test Menu and Assay Development/Validation
- Quality Assurance and Quality Control (QA/QC)
- Personnel and Training
- Data Management and Reporting
- Biosafety and Biosecurity
- Regulatory Compliance
- Maintenance and Support
Service Level Agreement For Molecular Diagnostics Labs
This Service Level Agreement (SLA) outlines the guaranteed response times and uptime for molecular diagnostics laboratory services provided by [Your Company Name] to [Client Name]. This SLA is effective from [Start Date] to [End Date].
| Service Category | Guaranteed Response Time (during Service Hours) | Uptime Guarantee | Notes/Escalation |
|---|---|---|---|
| Sample Receipt & Initial Processing: | Acknowledgement of receipt within [e.g., 2 business hours] of delivery. | N/A (Focus is on processing time, not availability) | Confirmation of sample integrity and suitability for testing will be provided within [e.g., 4 business hours] of receipt. |
| Critical Result Notification: | Notification to designated client contact within [e.g., 1 hour] of confirmation. | N/A | Notification method (phone, secure fax, EHR alert) to be agreed upon. |
| Routine Test Result Reporting: | Target reporting turnaround time (TAT) for specific assays will be detailed in Exhibit A. Response to queries about TAT within [e.g., 4 business hours]. | N/A (Focus is on TAT, not uptime) | TATs are subject to sample quality and volume. |
| Technical Support (Instrumentation/Assay Issues): | Initial response within [e.g., 4 business hours] for non-critical issues. Within [e.g., 1 business hour] for critical issues impacting multiple tests or clients. | [e.g., 99.5%] (excluding Scheduled Maintenance) | For critical issues, an RCA will be provided within [e.g., 48 business hours] of resolution. |
| Data Access & LIMS Availability: | N/A (focus is on continuous availability) | [e.g., 99.9%] (excluding Scheduled Maintenance) | Scheduled maintenance notifications will be provided at least [e.g., 7 days] in advance. Unscheduled downtime exceeding [e.g., 2 hours] will trigger a notification to the client. |
| Reagent/Consumable Supply Chain Management: | Response to urgent supply requests within [e.g., 2 business hours]. | N/A | Proactive communication regarding potential supply chain disruptions. |
Definitions
- Service Hours: The period during which laboratory services are available and support is provided. Typically [e.g., 24/7, 9 AM - 5 PM Local Time, Monday - Friday].
- Response Time: The maximum allowable time from when a request is initiated (e.g., sample submission, critical result notification, technical support query) until a designated representative from [Your Company Name] acknowledges and begins addressing the request.
- Uptime: The percentage of time that the molecular diagnostics laboratory systems, platforms, and essential operational functions are available and performing as expected. Downtime is any period where services are unavailable due to technical issues, maintenance, or other factors outside the client's control.
- Critical Result: A result that indicates a condition requiring immediate medical attention or intervention, as defined by [Your Company Name]'s standard operating procedures and communicated to the client.
- Scheduled Maintenance: Pre-announced periods of planned downtime for system updates, calibration, or preventative maintenance.
- Unscheduled Downtime: Any period of service unavailability not covered by Scheduled Maintenance.
- Root Cause Analysis (RCA): An investigation into the fundamental cause of a service disruption or failure.
In-Depth Guidance
Frequently Asked Questions
Phase 02: Execution
Ready when you are
Let's scope your Molecular Diagnostics Labs in Burkina Faso project in Burkina Faso.
OEM Approved
54Regions
Scaling healthcare logistics and technical systems across the entire continent.